Rosa David A
Transaction: 03/12/2023
BUY
Change
+75,930
Price
$1.94
Filing
03/15/2023
Type
BUY
Biotricity, Inc.
BTCY • Medical - Devices
Strong market move
BTCY+19.57%
vs. previous close $0.05
$0.06
▲ +0.01 (+19.57%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.27M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.16Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.06
Change19.57%
Shares Out23.10M
Market Cap$1.27M
Enterprise Value$26.86M
52W Range0.09 - 0.75
Beta1.15
P/E-0.45
P/S0.08
P/B-0.04
P/FCF7.86
EV/Sales1.64
Price$0.06
Change19.57%
Shares Out23.10M
Market Cap$1.27M
Enterprise Value$26.86M
52W Range0.09 - 0.75
Beta1.15
P/E-0.45
P/S0.08
P/B-0.04
P/FCF7.86
EV/Sales1.64
EV/EBITDA15.02
EV/FCF166.17
Earnings Yield-220.61%
FCF Yield12.73%
Dividend Yield0.73%
Gross Margin80.94%
Oper. Margin10.57%
Profit Margin-15.03%
Debt/Eq-0.82
Current Ratio0.16
Quick Ratio0.12
Target$4.00
Target Upside7172.73%
Target Median$4.00
Target Range4.00 - 4.00
Volume8.00
Avg Volume56.52K
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
31/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Weak liquidity · 0.16Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-10-21
75/100
Bullish
Bullish
2
Hold
2
Bearish
0
Price Target
2026-08-21
Low
$4.00
Mean
$4.00
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
Al-Siddiq Waqaas
Transaction: 03/12/2023
BUY
Change
+350,000
Price
$1.25
Filing
03/14/2023
Type
BUY
Ayanoglou John
Transaction: 12/31/2022
BUY
Change
+218,785
Price
$0.45
Filing
03/13/2023
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rosa David A | BUY | +75,930 | $1.94 | 03/12/2023 | 03/15/2023 |
| Al-Siddiq Waqaas | BUY | +350,000 | $1.25 | 03/12/2023 | 03/14/2023 |
| Ayanoglou John | BUY | +218,785 | $0.45 | 12/31/2022 | 03/13/2023 |
| Ayanoglou John | BUY | +118,282 | $0.80 | 09/30/2022 | 03/13/2023 |
| Ayanoglou John | BUY | +53,827 | $1.77 | 06/30/2022 | 03/13/2023 |
| Ayanoglou John | BUY | +37,594 | $2.27 | 03/31/2022 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $2.40 | 12/31/2021 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $2.40 | 09/30/2021 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $2.40 | 06/30/2021 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $2.40 | 03/31/2021 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.74 | 12/31/2020 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $1.11 | 09/30/2020 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $1.37 | 06/30/2020 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.97 | 03/31/2020 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.75 | 01/24/2020 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.63 | 12/31/2019 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.58 | 09/30/2019 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.66 | 06/30/2019 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.91 | 03/31/2019 | 03/13/2023 |
| Ayanoglou John | BUY | +50,000 | $0.48 | 12/31/2018 | 03/13/2023 |